Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes.
<h4>Background</h4>Obesity and type 2 diabetes (T2DM) are associated with increased circulating free fatty acids and triacylglycerols. However, very little is known about specific molecular lipid species associated with these diseases. In order to gain further insight into this, we perfo...
Guardado en:
Autores principales: | Melissa N Barber, Steve Risis, Christine Yang, Peter J Meikle, Margaret Staples, Mark A Febbraio, Clinton R Bruce |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4a5ef9c8adb5469989a37f6048e03059 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3
por: Qing Zhang, et al.
Publicado: (2021) -
Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance
por: Alexia Karen Cotte, et al.
Publicado: (2018) -
Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients
por: Zhou X, et al.
Publicado: (2021) -
Diagnosis and mortality prediction of sepsis via lysophosphatidylcholine 16:0 measured by MALDI-TOF MS
por: Eun Hye Lee, et al.
Publicado: (2020) -
Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?
por: Mba CM, et al.
Publicado: (2019)